These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24521717)

  • 21. Type 2 diabetes and coronary artery disease: Preserved ejection fraction and sudden cardiac death.
    Junttila MJ; Kiviniemi AM; Lepojärvi ES; Tulppo M; Piira OP; Kenttä T; Perkiömäki JS; Ukkola OH; Myerburg RJ; Huikuri HV
    Heart Rhythm; 2018 Oct; 15(10):1450-1456. PubMed ID: 30274618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sudden cardiac death in adult congenital heart disease: can the unpredictable be foreseen?
    Koyak Z; de Groot JR; Bouma BJ; Zwinderman AH; Silversides CK; Oechslin EN; Budts W; Van Gelder IC; Mulder BJ; Harris L
    Europace; 2017 Mar; 19(3):401-406. PubMed ID: 27247006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study.
    Piccirillo G; Magrì D; Matera S; Magnanti M; Torrini A; Pasquazzi E; Schifano E; Velitti S; Marigliano V; Quaglione R; Barillà F
    Eur Heart J; 2007 Jun; 28(11):1344-50. PubMed ID: 17101636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.
    Kreuz J; Horlbeck F; Schrickel J; Linhart M; Fimmers R; Mellert F; Nickenig G; Schwab JO
    Clin Cardiol; 2012 Sep; 35(9):575-9. PubMed ID: 22707222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ; Ottesen MM; Rask-Madsen C; Andersen PK; Rosthøj S; Torp-Pedersen C; Køber L
    Int J Cardiol; 2005 Sep; 104(2):184-9. PubMed ID: 16168812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV Infection and the Risk of World Health Organization-Defined Sudden Cardiac Death.
    Freiberg MS; Duncan MS; Alcorn C; Chang CH; Kundu S; Mumpuni A; Smith EK; Loch S; Bedigian A; Vittinghoff E; So-Armah K; Hsue PY; Justice AC; Tseng ZH
    J Am Heart Assoc; 2021 Sep; 10(18):e021268. PubMed ID: 34493058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac Function and Sudden Cardiac Death in Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial).
    Kalra R; Gupta K; Sheets R; Aryal S; Ebrahimi A; Rajapreyar I; Cribbs MG; Booker OJ; Prabhu SD; Bajaj NS
    Am J Cardiol; 2020 Aug; 129():46-52. PubMed ID: 32563496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease.
    Reinier K; Dervan C; Singh T; Uy-Evanado A; Lai S; Gunson K; Jui J; Chugh SS
    Heart Rhythm; 2011 Aug; 8(8):1177-82. PubMed ID: 21376836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.
    Adabag S; Patton KK; Buxton AE; Rector TS; Ensrud KE; Vakil K; Levy WC; Poole JE
    JAMA Cardiol; 2017 Jul; 2(7):767-774. PubMed ID: 28724134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of beat-to-beat QT variability index across the continuum of left ventricular dysfunction: competing risks of noncardiac or cardiovascular death and sudden or nonsudden cardiac death.
    Tereshchenko LG; Cygankiewicz I; McNitt S; Vazquez R; Bayes-Genis A; Han L; Sur S; Couderc JP; Berger RD; de Luna AB; Zareba W
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):719-27. PubMed ID: 22730411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resting heart rate and risk of sudden cardiac death in the general population: influence of left ventricular systolic dysfunction and heart rate-modulating drugs.
    Teodorescu C; Reinier K; Uy-Evanado A; Gunson K; Jui J; Chugh SS
    Heart Rhythm; 2013 Aug; 10(8):1153-8. PubMed ID: 23680897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An association between right ventricular dysfunction and sudden cardiac death.
    Pandat S; Nagaura T; Nair SG; Uy-Evanado A; Stecker EC; Nichols GA; Jui J; Shiota T; Chugh SS; Reinier K
    Heart Rhythm; 2020 Feb; 17(2):169-174. PubMed ID: 31634617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
    Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic Function.
    Aleong RG; Mulvahill MJ; Halder I; Carlson NE; Singh M; Bloom HL; Dudley SC; Ellinor PT; Shalaby A; Weiss R; Gutmann R; Sauer WH; Narayanan K; Chugh SS; Saba S; London B
    J Am Heart Assoc; 2015 Jul; 4(8):e001566. PubMed ID: 26231842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Benefit of Successful Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients With Versus Without Reduced (≤40%) Left Ventricular Ejection Fraction.
    Toma A; Stähli BE; Gick M; Gebhard C; Kaufmann BA; Mashayekhi K; Ferenc M; Buettner HJ; Neumann FJ
    Am J Cardiol; 2017 Nov; 120(10):1780-1786. PubMed ID: 28867125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seasonal variation in the frequency of sudden cardiac death and ventricular tachyarrhythmia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: the effect of meteorological factors.
    Chung FP; Li HR; Chong E; Pan CH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Lin WY; Shaw KP; Chen SA
    Heart Rhythm; 2013 Dec; 10(12):1859-66. PubMed ID: 24080066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular dysfunction after mitral valve repair--the fallacy of "normal" preoperative myocardial function.
    Quintana E; Suri RM; Thalji NM; Daly RC; Dearani JA; Burkhart HM; Li Z; Enriquez-Sarano M; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2752-60. PubMed ID: 25173130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.